Skip to main content

Table 3 The association between the arterial transit artifact and 3-month outcomes stratified by TOAST subtypes

From: Arterial transit artifact as a short-term prognostic indicator in acute ischemic stroke

   

Risk ratios (95% CI)

 

n

3-month mRS > 2

Unadjusted

Adjusteda

LAA

44

   

ATA present

35

5 (14.29)

0.26 (0.09- 0.70)

0.20 (0.05—0.72)

ATA absent

9

5 (55.56)

Reference

Reference

CE

17

   

ATA present

5

2 (40.00)

1.20 (0.31—4.58)

3.55 (0.43—29.27)

ATA absent

12

4 (33.33)

Reference

Reference

SVO

37

   

ATA present

6

1 (16.67)

0.52 (0.08—3.32)

0.51 (0.08—3.57)

ATA absent

31

10 (32.26)

Reference

Reference

  1. ATA arterial transit artifact, TOAST Trial of ORG 10172 in Acute Stroke Treatment, LAA large-artery atherosclerosis, CE cardioembolism, SVO small-vessel occlusion, mRS modified Rankin Scale
  2. aAdjusted for potential confounders (NIHSS at baseline and infarct volume)